trending Market Intelligence /marketintelligence/en/news-insights/trending/PfAZ6FWLyVbh1NEqVe0Paw2 content esgSubNav
In This List

Eli Lilly, Boehringer launch insulin in US

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Eli Lilly, Boehringer launch insulin in US

Eli Lilly & Co. and Boehringer Ingelheim Corp. launched Basaglar in the U.S. market.

The insulin will compete with Sanofi's Lantus to treat patients with type 1 diabetes and adults with type 2 diabetes.